{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:50:15Z","timestamp":1774450215548,"version":"3.50.1"},"reference-count":35,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.3892\/br.2016.622","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T14:20:50Z","timestamp":1457014850000},"page":"642-648","source":"Crossref","is-referenced-by-count":12,"title":["Soluble cluster of differentiation 36 concentrations are not associated with cardiovascular risk factors in middle-aged subjects"],"prefix":"10.3892","volume":"4","author":[{"given":"MOHAMMAD J.","family":"ALKHATATBEH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NEHAD M.","family":"AYOUB","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NIZAR M.","family":"MHAIDAT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NESREEN A.","family":"SAADEH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LISA F.","family":"LINCZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,3,3]]},"reference":[{"key":"key20180107141018_b1-br-0-0-622","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","article-title":"Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations","volume":"168","author":"Finegold","year":"2013","journal-title":"Int J Cardiol"},{"key":"key20180107141018_b2-br-0-0-622","first-page":"51","article-title":"Non-modifiable factors of coronary artery stenosis in late onset patients with coronary artery disease in Southern Iranian population","volume":"6","author":"Tabei","year":"2014","journal-title":"J Cardiovasc Thorac Res"},{"key":"key20180107141018_b3-br-0-0-622","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1098-3597(07)80025-1","article-title":"Cardiovascular disease and modifiable cardiometabolic risk factors","volume":"8","author":"Cannon","year":"2007","journal-title":"Clin Cornerstone"},{"key":"key20180107141018_b4-br-0-0-622","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1210\/jc.2006-0513","article-title":"Metabolic syndrome: A multiplex cardiovascular risk factor","volume":"92","author":"Grundy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107141018_b5-br-0-0-622","first-page":"31","year":"1999","journal-title":"Consultation WHO Definition, diagnosis and classification of diabetes mellitus and its complications"},{"key":"key20180107141018_b6-br-0-0-622","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"European Group for the Study of Insulin Resistance (EGIR): Comment on the provisional report from the WHO consultation","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"key":"key20180107141018_b7-br-0-0-622","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"key20180107141018_b8-br-0-0-622","article-title":"International Diabetes Federation: The IDF Consensus Worldwide Definition of the Metabolic Syndrome","year":"2006","journal-title":"International Diabetes Federation"},{"key":"key20180107141018_b9-br-0-0-622","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2796.2012.02589.x","article-title":"Identifying novel biomarkers for cardiovascular disease risk prediction","volume":"272","author":"Ge","year":"2012","journal-title":"J Intern Med"},{"key":"key20180107141018_b10-br-0-0-622","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jama.290.7.898","article-title":"Prevalence of conventional risk factors in patients with coronary heart disease","volume":"290","author":"Khot","year":"2003","journal-title":"JAMA"},{"key":"key20180107141018_b11-br-0-0-622","first-page":"37","article-title":"Metabolic biomarkers for predicting cardiovascular disease","volume":"9","author":"Montgomery","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"key20180107141018_b12-br-0-0-622","doi-asserted-by":"crossref","first-page":"e62080","DOI":"10.1371\/journal.pone.0062080","article-title":"Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses","volume":"8","author":"van Holten","year":"2013","journal-title":"PLoS One"},{"key":"key20180107141018_b13-br-0-0-622","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00041433-199610000-00012","article-title":"Macrophages and atherosclerotic plaque stability","volume":"7","author":"Libby","year":"1996","journal-title":"Curr Opin Lipidol"},{"key":"key20180107141018_b14-br-0-0-622","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/CIRCULATIONAHA.106.626135","article-title":"Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: A novel marker of insulin resistance","volume":"114","author":"Handberg","year":"2006","journal-title":"Circulation"},{"key":"key20180107141018_b15-br-0-0-622","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1038\/emm.2014.38","article-title":"CD36, a scavenger receptor implicated in atherosclerosis","volume":"46","author":"Park","year":"2014","journal-title":"Exp Mol Med"},{"key":"key20180107141018_b16-br-0-0-622","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1079\/PNS2004331","article-title":"Regulation of fatty acid transport by fatty acid translocase\/CD36","volume":"63","author":"Bonen","year":"2004","journal-title":"Proc Nutr Soc"},{"key":"key20180107141018_b17-br-0-0-622","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1038\/nutd.2013.1","article-title":"The origin of circulating CD36 in type 2 diabetes","volume":"3","author":"Alkhatatbeh","year":"2013","journal-title":"Nutr Diabetes"},{"key":"key20180107141018_b18-br-0-0-622","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/dc07-1424","article-title":"Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment","volume":"31","author":"Glintborg","year":"2008","journal-title":"Diabetes Care"},{"key":"key20180107141018_b19-br-0-0-622","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/STROKEAHA.108.517128","article-title":"Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability","volume":"39","author":"Handberg","year":"2008","journal-title":"Stroke"},{"key":"key20180107141018_b20-br-0-0-622","doi-asserted-by":"crossref","first-page":"316170","DOI":"10.1186\/1687-9856-2010-316170","article-title":"Metabolic Syndrome and Its Individual Components among Jordanian Children and Adolescents","volume":"2010","author":"Khader","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"issue":"Suppl 1","key":"key20180107141018_b21-br-0-0-622","first-page":"S62","article-title":"American Diabetes Association: Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"key20180107141018_b22-br-0-0-622","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2261-14-54","article-title":"Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects","volume":"14","author":"Ramos-Arellano","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"key20180107141018_b23-br-0-0-622","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.chemosphere.2015.04.096","article-title":"Association of chemical constituents and pollution sources of ambient fine particulate air pollution and biomarkers of oxidative stress associated with atherosclerosis: A panel study among young adults in Beijing, China","volume":"135","author":"Wu","year":"2015","journal-title":"Chemosphere"},{"key":"key20180107141018_b24-br-0-0-622","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3109\/00365513.2015.1031693","article-title":"Is plasma soluble CD36 associated with cardiovascular risk factors in early onset coronary artery disease patients?","volume":"75","author":"Krzystolik","year":"2015","journal-title":"Scand J Clin Lab Invest"},{"key":"key20180107141018_b25-br-0-0-622","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1758-5996-5-51","article-title":"Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease","volume":"5","author":"Himoto","year":"2013","journal-title":"Diabetol Metab Syndr"},{"key":"key20180107141018_b26-br-0-0-622","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/eci.12192","article-title":"Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease","volume":"44","author":"Garc\u00eda-Monz\u00f3n","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"key20180107141018_b27-br-0-0-622","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.thromres.2015.03.002","article-title":"Diverse CD36 expression among Japanese population: Defective CD36 mutations cause platelet and monocyte CD36 reductions in not only deficient but also normal phenotype subjects","volume":"135","author":"Masuda","year":"2015","journal-title":"Thromb Res"},{"key":"key20180107141018_b28-br-0-0-622","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1182\/blood-2011-02-338582","article-title":"Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms","volume":"117","author":"Ghosh","year":"2011","journal-title":"Blood"},{"key":"key20180107141018_b29-br-0-0-622","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jnutbio.2005.12.007","article-title":"Induction of Cd36 expression elicited by fish oil PUFA in spontaneously hypertensive rats","volume":"17","author":"Alexander","year":"2006","journal-title":"J Nutr Biochem"},{"key":"key20180107141018_b30-br-0-0-622","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/89969","article-title":"A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation","volume":"7","author":"Griffin","year":"2001","journal-title":"Nat Med"},{"key":"key20180107141018_b31-br-0-0-622","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1016\/S0021-9258(18)83273-2","article-title":"Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion","volume":"264","author":"Tandon","year":"1989","journal-title":"J Biol Chem"},{"key":"key20180107141018_b32-br-0-0-622","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1038\/nutd.2014.11","article-title":"Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals","volume":"4","author":"Kn\u00f8sgaard","year":"2014","journal-title":"Nutr Diabetes"},{"key":"key20180107141018_b33-br-0-0-622","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2796.2011.02442.x","article-title":"RISC Investigators: Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population","volume":"271","author":"Handberg","year":"2012","journal-title":"J Intern Med"},{"key":"key20180107141018_b34-br-0-0-622","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1538-7836.2011.04220.x","article-title":"The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles","volume":"9","author":"Alkhatatbeh","year":"2011","journal-title":"J Thromb Haemost"},{"key":"key20180107141018_b35-br-0-0-622","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.cca.2010.09.009","article-title":"Serum soluble CD36, assessed by a novel monoclonal antibody-based sandwich ELISA, predicts cardiovascular mortality in dialysis patients","volume":"411","author":"Chmielewski","year":"2010","journal-title":"Clin Chim Acta"}],"container-title":["Biomedical Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/br.2016.622\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T14:22:59Z","timestamp":1654525379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/br.2016.622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,3]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,3,3]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.3892\/br.2016.622"],"URL":"https:\/\/doi.org\/10.3892\/br.2016.622","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,3]]}}}